Dechra Pharmaceuticals

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Our key focus therapeutic areas are: • Endocrinology • Dermatology • Anaesthesia and analgesia • Ophthalmology • Cardiovascular disease • Equine locomotion • Food producing animal antimicrobials • And pet diets
Type
Public
HQ
Lostock Gralam, GB
Founded
1997
Employees
863 (est)
Dechra Pharmaceuticals was founded in 1997 and is headquartered in Lostock Gralam, GB

Dechra Pharmaceuticals Locations

Lostock Gralam, GB
Barcelona, ES
Uldum, DK
Upplands Väsby, SE
Pointe-Claire, CA
Leawood, US
Melbourne, US
Hadnall, GB
Torino, IT
Skipton, GB

Dechra Pharmaceuticals Metrics

Dechra Pharmaceuticals Summary

Market capitalization

£1.31 B

Closing share price

£14.2
Dechra Pharmaceuticals's current market capitalization is £1.31 B.

Dechra Pharmaceuticals Financials

Dechra Pharmaceuticals's revenue is £203 M in FY, 2015 which is 5.12% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

£189 M£194 M£203 M

Revenue growth, %

2.3%5.1%

Cost of sales

£88.5 M£85.9 M£87.3 M

Gross profit

£101 M£108 M£116 M

Gross profit Margin, %

53.2%55.6%57.1%

Operating expense total

£82.4 M£82.7 M£90.2 M

    Dechra Pharmaceuticals Market Value History

    Dechra Pharmaceuticals Online Presence

    Dechra Pharmaceuticals News

    Dechra Pharmaceuticals Company Life

    You may also be interested in